Longitudinal characterization of renal proximal tubular markers in normotensive and preeclamptic pregnancies

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 312, Issue 5, 2017, Pages R773-R778

  Codsi, Elisabeth ^a   Garovic, Vesna D ^a   Gonzalez Suarez, Maria L ^a   Milic, Natasa ^b   Borowski, Kristi S ^a   Rose, Carl H ^a   Davies, Norman P ^a   Kashani, Kianoush B ^a   Lieske, John C ^a   White, Wendy M ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Kidney disease; Preeclampsia; Tubular injury

Indexed keywords

ALPHA 1 MICROGLOBULIN; BIOLOGICAL MARKER; COMPLEMENT MEMBRANE ATTACK COMPLEX; CREATININE; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; KIDNEY INJURY MOLECULE 1; RETINOL BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; ALPHA GLOBULIN; ALPHA-1-MICROGLOBULIN; AUTACOID;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COHORT ANALYSIS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY CONCENTRATING CAPACITY; KIDNEY PROXIMAL TUBULE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OBSTETRIC DELIVERY; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; TUBULAR DYSFUNCTION; URINE SAMPLING; CAUSALITY; IMMUNOLOGY; KIDNEY DISEASES; MINNESOTA; PRE-ECLAMPSIA; PREVALENCE; RISK FACTOR; URINE;

ADULT; ALPHA-GLOBULINS; BIOMARKERS; CAUSALITY; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; FEMALE; HUMANS; INFLAMMATION MEDIATORS; KIDNEY DISEASES; KIDNEY TUBULES, PROXIMAL; LONGITUDINAL STUDIES; MINNESOTA; PRE-ECLAMPSIA; PREGNANCY; PREVALENCE; RISK FACTORS;

EID: 85019988772     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00509.2016     Document Type: Article

References (51)

1. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122: 1122-1131, 2013. doi: 10.1097/01.AOG.0000437382.03963.88.
2. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 114: 1326-1331, 2009. doi:10.1097/AOG.0b013e3181c2bde8
3. Acharya A, Santos J, Linde B, Anis K. Acute kidney injury in pregnancy-current status. Adv Chronic Kidney Dis 20: 215-222, 2013. doi:10.1053/j.ackd.2013.02.002.
4. Åkerström B, Lögdberg L, Berggård T, Osmark P, Lindqvist A. alpha(1)-Microglobulin: a yellow-brown lipocalin. Biochim Biophys Acta 1482: 172-184, 2000. doi:10.1016/S0167-4838(00)00157-6
5. Akerström B, Maghzal GJ, Winterbourn CC, Kettle AJ. The lipocalin alpha1-microglobulin has radical scavenging activity. J Biol Chem 282: 31493-31503, 2007. doi:10.1074/jbc.M702624200.
6. Allhorn M, Berggård T, Nordberg J, Olsson ML, Akerström B. Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood 99: 1894-1901, 2002. doi:10.1182/blood.V99.6.1894.
7. Allhorn M, Klapyta A, Akerström B. Redox properties of the lipocalin alpha1-microglobulin: reduction of cytochrome c, hemoglobin, and free iron. Free Radic Biol Med 38: 557-567, 2005. doi:10.1016/j.freeradbiomed.2004.12.013.
8. Berggård T, Thelin N, Falkenberg C, Enghild JJ, Akerström B. Prothrombin, albumin and immunoglobulin A form covalent complexes with alpha1-microglobulin in human plasma. Eur J Biochem 245: 676-683, 1997. doi:10.1111/j.1432-1033.1997.00676.x.
9. Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camussi G. Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 45: 451-460, 1994. doi:10.1038/ki.1994.59.
10. Bouic P, Vincent C, Revillard JP. Localization of 1-microglobulin (HC protein) in normal human tissues: an immunohistochemical study using monoclonal antibodies. Histochem J 16: 1311-1324, 1984. doi:10.1007/BF01003728.
11. Burwick RM, Easter SR, Dawood HY, Yamamoto HS, Fichorova RN, Feinberg BB. Complement activation and kidney injury molecule-1-associated proximal tubule injury in severe preeclampsia. Hypertension 64: 833-838, 2014. doi:10.1161/HYPERTENSIONAHA.114.03456.
12. Burwick RM, Fichorova RN, Dawood HY, Yamamoto HS, Feinberg BB. Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy. Hypertension 62: 1040-1045, 2013. doi:10.1161/HYPERTENSIONAHA.113.01420.
13. Buurma A, Cohen D, Veraar K, Schonkeren D, Claas FH, Bruijn JA, Bloemenkamp KW, Baelde HJ. Preeclampsia is characterized by placental complement dysregulation. Hypertension 60: 1332-1337, 2012. doi:10.1161/HYPERTENSIONAHA.112.194324.
14. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 10: 466-480, 2014. doi:10.1038/nrneph.2014.102.
15. Craici IM, Wagner SJ, Bailey KR, Fitz-Gibbon PD, Wood-Wentz CM, Turner ST, Hayman SR, White WM, Brost BC, Rose CH, Grande JP, Garovic VD. Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 61: 1289-1296, 2013. doi:10.1161/HYPERTENSIONAHA.113.01115.
16. Craici IM, Wagner SJ, Weissgerber TL, Grande JP, Garovic VD. Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int 86: 275-285, 2014. doi:10.1038/ki.2014.17.
17. Davison JM. The kidney in pregnancy: a review. J R Soc Med 76: 485-501, 1983.
18. Garovic VD. The role of the podocyte in preeclampsia. Clin J Am Soc Nephrol 9: 1337-1340, 2014. doi:10.2215/CJN.05940614.
19. Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, Brost BC, Rose CH, Gavrilova L, Craigo P, Bailey KR, Achenbach J, Schiffer M, Grande JP. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 196: 320e1-320e7, 2007. doi:10.1016/j.ajog.2007.02.007.
20. Girardi G, Salmon JB. The role of complement in pregnancy and fetal loss. Autoimmunity 36: 19-26, 2003. doi:10.1080/0891693031000067322.
21. Gram M, Anderson UD, Johansson ME, Edström-Hägerwall A, Larsson I, Jälmby M, Hansson SR, Åkerström B. The human endogenous protection system against cell-free hemoglobin and heme is overwhelmed in preeclampsia and provides potential biomarkers and clinical indicators. PLoS One 10: e0138111, 2015. doi:10.1371/journal.pone.0138111.
22. Grubb AO, López C, Tejler L, Mendez E. Isolation of human complex-forming glycoprotein, heterogeneous in charge (protein HC), and its IgA complex from plasma. Physiochemical and immunochemical properties, normal plasma concentration. J Biol Chem 258: 14698-14707, 1983.
23. Hänsch GM, Seitz M, Betz M. Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int Arch Allergy Appl Immunol 82: 317-320, 1987. doi:10.1159/000234216.
24. Karthikeyan VJ, Lane DA, Beevers DG, Lip GY, Blann AD. Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications. J Hum Hypertens 27: 72-78, 2013. doi:10.1038/jhh.2012.8.
25. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmelé T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17: R25, 2013. doi:10.1186/cc12503.
26. Kerjaschki D, Schulze M, Binder S, Kain R, Ojha PP, Susani M, Horvat R, Baker PJ, Couser WG. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 143: 546-552, 1989.
27. Kilgore KS, Schmid E, Shanley TP, Flory CM, Maheswari V, Tramontini NL, Cohen H, Ward PA, Friedl HP, Warren JS. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol 150: 2019-2031, 1997.
28. Koyner JL, Shaw AD, Chawla LS, Hoste EA, Bihorac A, Kashani K, Haase M, Shi J, Kellum JA; Sapphire Investigators. Tissue inhibitor metalloproteinase-2 (TIMP-2)IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 26: 1747-1754, 2015. doi:10.1681/ASN.2014060556.
29. Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 113: 1299-1306, 2009. doi:10.1097/AOG.0b013e3181a45b25.
30. Larsson A, Palm M, Hansson LO, Axelsson O. Reference values for clinical chemistry tests during normal pregnancy. BJOG 115: 874-881, 2008. doi:10.1111/j.1471-0528.2008.01709.x.
31. Larsson J, Allhorn M, Åkerström B. The lipocalin alpha(1)-microglobulin binds heme in different species. Arch Biochem Biophys 432: 196-204, 2004. doi:10.1016/j.abb.2004.09.021.
32. Lynch AM, Salmon JE. Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta 31: 561-567, 2010. doi:10.1016/j.placenta.2010.03.010.
33. May K, Rosenlöf L, Olsson MG, Centlow M, Mörgelin M, Larsson I, Cederlund M, Rutardottir S, Siegmund W, Schneider H, Akerström B, Hansson SR. Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by 1-microglobulin. Placenta 32: 323-332, 2011. doi:10.1016/j.placenta.2011.01.017.
34. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J Am Soc Nephrol 14: 2178-2187, 2003. doi:10.1097/01.ASN.0000079042.13465.1A.
35. Morita Y, Ikeguchi H, Nakamura J, Hotta N, Yuzawa Y, Matsuo S. Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol 11: 700-707, 2000.
36. National High Blood Pressure Education Program Coordinating Committee. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183: S1-S22, 2000. doi:10.1067/mob.2000.107928.
37. Olsson MG, Olofsson T, Tapper H, Akerstrom B. The lipocalin alpha1-microglobulin protects erythroid K562 cells against oxidative damage induced by heme and reactive oxygen species. Free Radic Res 42: 725-736, 2008. doi:10.1080/10715760802337265.
38. Paternoster DM, Stella A, Babbo GL, Pignataro R, Mussap M, Plebani M. Markers of tubular damage in pre-eclampsia. Minerva Ginecol 51: 373-377, 1999.
39. Penders J, Delanghe JR. Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta 346: 107-118, 2004. doi:10.1016/j.cccn.2004.03.037.
40. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180: 499-506, 1999. doi:10.1016/S0002-9378(99)70239-5.
41. Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien JK, Edwin S, Kim YM, Hong JS, Mazor M. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonatal Med 17: 239-245, 2005. doi:10.1080/14767050500072722.
42. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161: 1200-1204, 1989. doi:10.1016/0002-9378(89)90665-0.
43. Saudan PJ, Farrell TJ, Brown MA. Beta2-microglobulin in hypertensive pregnancies. Am J Kidney Dis 31: 308-312, 1998. doi:10.1053/ajkd.1998.v31.pm9469502.
44. Schiller B, Cunningham PN, Alexander JJ, Bao L, Holers VM, Quigg RJ. Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure. J Am Soc Nephrol 12: 71-79, 2001.
45. Seeger W, Suttorp N, Hellwig A, Bhakdi S. Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes. J Immunol 137: 1286-1293, 1986.
46. Semczuk-Sikora A, Sikora P, Semczuk M. [Urinary N-acetyl-beta-Dglucosaminidase (NAG) activity in women with preeclampsia]. Ginekol Pol 71: 141-145, 2000.
47. Spargo BH, Lichtig C, Luger AM, Katz AI, Lindheimer MD. The renal lesion in preeclampsia. Perspect Nephrol Hypertens 5: 129-137, 1976.
48. Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 18: 2281-2284, 2007. doi:10.1681/ASN.2007020255.
49. Weissgerber TL, Craici IM, Wagner SJ, Grande JP, Garovic VD. Advances in the pathophysiology of preeclampsia and related podocyte injury. Kidney Int 86: 445, 2014. doi:10.1038/ki.2014.221.
50. Xiao J, Niu J, Ye X, Yu Q, Gu Y. Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia. Hypertens Pregnancy 32: 439-449, 2013. doi:10.3109/10641955.2013.827203.
51. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105: 1363-1371, 2000. doi:10.1172/JCI8621